Key Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KEY THERAP
KEY THERAP has four approved drugs.
There is one US patent protecting KEY THERAP drugs.
There are one hundred and fifty-five patent family members on KEY THERAP drugs in thirty-seven countries and twenty-two supplementary protection certificates in sixteen countries.
Summary for Key Therap
| International Patents: | 155 |
| US Patents: | 1 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Key Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Therap | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785-001 | Nov 26, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | DISCN | Yes | No | 7,304,078 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Key Therap | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 088237-001 | Apr 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Key Therap | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 206615-001 | Aug 4, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Key Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,235,567 | ⤷ Start Trial |
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,713,999 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Key Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2004276327 | ⤷ Start Trial |
| Denmark | 2065384 | ⤷ Start Trial |
| Austria | 494284 | ⤷ Start Trial |
| Japan | 2004503551 | ⤷ Start Trial |
| Malaysia | 130642 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Key Therap Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1495018 | 2015/035 | Ireland | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119 |
| 1495018 | S1500036 | Hungary | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR; REGISTRATION NO/DATE: EU/1/14/976 20150119 |
| 1495018 | C01495018/01 | Switzerland | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65803 19.09.2016 |
| 1495018 | 122015000053 | Germany | ⤷ Start Trial | PRODUCT NAME: VORAPAXAR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119 |
| 1495018 | C20150025 00159 | Estonia | ⤷ Start Trial | PRODUCT NAME: VORAPAKSAAR;REG NO/DATE: EU/1/14/976 21.01.2015 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
